AG: All Indiana communities now participating in $507M opioid settlement
The Attorney General’s office reported all 648 political subdivisions in Indiana have joined the settlement, which is part of a roughly $26 billion payout across 46 states.
Pharmaceutical
Articles
FDA advisers back Novavax COVID-19 shots as new option
Novavax shots are already used in Australia, Canada, parts of Europe and dozens of other countries. But U.S. clearance is a key hurdle for the Maryland-based company.
Pharma company plans $220M expansion in Indiana, 80 new jobs
Germany-based Evonik announced Thursday that it will expand its pharmaceutical production facility in Lafayette. The plant will build produce lipids for mRNA-based therapies in the United States.
Lilly to anchor state’s new innovation district with $2.1B in manufacturing facilities
The Indianapolis-based drugmaker said Wednesday the project in Boone County will create up to 500 jobs in central Indiana, along with up to 1,500 temporary construction jobs.
FDA approves Lilly diabetes drug that helps patients lose weight
The drug has been closely watched by medical professionals and is viewed by financial analysts as a possible blockbuster, with potential annual sales in the billions of dollars.
Lilly’s new weight-loss drug is a ‘double wow’ and likely blockbuster
The pharmaceutical giant is turning heads with an experimental medicine it claims can help obese patients shed nearly a quarter of their body weight and manage diabetes.
Life sciences experts say Indiana needs to push collaborations to compete with other states
A panel of Indiana life science experts on Friday said the state could become more competitive for large investments and jobs if it doubled down on the kind of collaborations and partnerships that other states have used to their advantage.
Lilly profit soars 40% in first quarter
Eli Lilly and Co. posted profit of $1.9 billion in the first quarter, up 40%, on higher sales of COVID-19 antibodies and other key products for diabetes, cancer and arthritis.
Moderna seeks to be first with COVID shots for littlest children
Moderna on Thursday asked U.S. regulators to authorize low doses of its COVID-19 vaccine for children younger than 6, a long-awaited move toward potentially opening shots for millions of tots by summer.
Lilly says experimental drug helped patients lose up to 22% of body weight
The drug, called tirzepatide, has been closely watched by medical professionals and is viewed by financial analysts as possible blockbuster, with potential annual sales in the billions of dollars.
Administration expanding availability of COVID antiviral pill
Paxlovid, when administered within five days of symptoms appearing, has been proven to bring about a 90% reduction in hospitalizations and deaths among patients most likely to get severe disease.
COVID shots still work, but researchers hunting new improvements
COVID-19 vaccinations are at a critical juncture as companies test whether new approaches like combination shots or nasal drops can keep up with a mutating coronavirus—even though it’s not clear if changes are needed.
Indianapolis-based Telix rolls out method for detecting cancer
The imaging agent is the six-year-old company’s first commercial launch, following millions of dollars’ worth of research and clinical tests. It was approved by the U.S. Food and Drug Administration in December.
Catalent to invest $350M in Bloomington operations, add 1,000 jobs through 2023
The expansion comes on top of more than 1,000 positions the drugmaker has added since Jan. 1, 2021, bringing its current Bloomington workforce total to more than 4,000, which includes employees and workers provided by staffing agencies.
Moderna takes step toward updating COVID shots for fall
Moderna hopes to offer updated COVID-19 boosters in the fall that combine its original vaccine with protection against the omicron variant.
Indy-based Acacia Pharma being acquired by New Jersey firm; fate of local operations unknown
Acacia Pharma Group employees are waiting to see what will happen to their jobs and whether the company will remain in Indianapolis in any form, now that it is being acquired by New Jersey-based specialty drugmaker Eagle Pharmaceuticals Inc. for $103.9 million.
Lilly says it will push ahead on Alzheimer’s drug
The push by Eli Lilly and Co. will come despite an unfavorable ruling last week from Medicare that sharply restricts reimbursements for a drug in the same class.
Medicare weighs premium cut after limiting Alzheimer’s drug
Thursday’s coverage decision illustrates the impact that a single medication can have on the budgets of individuals and taxpayers.
Several Indiana cities opting back in to opioid settlement
The state’s capital city, the suburbs of Noblesville and Fishers and other cities, including Muncie and Franklin, decided to join the statewide settlement after it was made more attractive by a new state law that gives local governments more direct funding and flexibility.
House passes $35-a-month insulin cap as Dems seek wider bill
The Affordable Insulin Now Act will serve as a political vehicle to rally Democrats and force Republicans who oppose it into uncomfortable votes ahead of the midterms.